Red Lighthouse Investment Management’s VanEck Biotech ETF BBH Stock Holding History

Red Lighthouse Investment Management’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-300	Closed	-$49.9K	–	115
2025 Q1	$49.9K	Hold	300	–	–	0.02%	92
2024 Q4	$47.1K	Hold	300	–	–	0.02%	95
2024 Q3	$53.2K	Hold	300	–	–	0.02%	93
2024 Q2	$50.5K	Buy	+300	New	+$49.1K	0.02%	91

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Red Lighthouse Investment Management's BBH Position: Q2 2025 in Review

Red Lighthouse Investment Management sold out of VanEck Biotech ETF (BBH) in Q2 2025, closing a stake of 300 shares — an estimated $49.9K sold.

Red Lighthouse Investment Management first reported a position in BBH in Q2 2024 and held it in 4 quarters. The position peaked at $53.2K in Q3 2024. 98 funds tracked by Wall St. Rank hold BBH as of Q2 2025.

Red Lighthouse Investment Management reported no remaining VanEck Biotech ETF position as of Q2 2025 after selling out during the quarter.
Red Lighthouse Investment Management sold 300 VanEck Biotech ETF shares in Q2 2025, an estimated $49.9K.
Red Lighthouse Investment Management first reported a position in VanEck Biotech ETF in Q2 2024 and held it in 4 quarters.
Red Lighthouse Investment Management's VanEck Biotech ETF position peaked at $53.2K in Q3 2024.
98 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2025.

Based on Red Lighthouse Investment Management's 13F filing for Q2 2025, filed 1 Aug 2025.